Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory approval and launch of their rapid, sensitive SARS-CoV-2 test.
We use cookies to give you the best experience on our website. More information can be found in our Cookie Policy. If you continue to use this site we will assume that you are happy with it.